Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism
|4||Active, not recruiting||
PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.
† Study has passed its completion date and status has not been verified in more than two years.